What is NDC 67457-756?

67457-756 is the product NDC for Octreotide Acetate kit, listed with the FDA by Mylan Institutional LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Mylan Institutional LLC, NDC labeler code 67457. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Octreotide Acetate?

28 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Octreotide Acetate NDC 67457-756 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)67457-756Labeler and product segments. Claims need a package NDC.

Product NDC at billing width67457-0756Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
67457-756-10	67457075610	1 KIT in 1 KIT (67457-756-10) * 6 mL in 1 VIAL (67457-754-10) * 2 mL in 1 SYRINGE (67457-755-02)Marketed from Jan 28, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Octreotide Acetate
Generic name (nonproprietary): octreotide acetate
Dosage form: Kit
Labeler: Mylan Institutional LLCNDC labeler code 67457
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216589
Marketing start: Jan 28, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 67457-756_49d0f367-0a1c-40e4-8732-f0c9ce935a44SPL ID 49d0f367-0a1c-40e4-8732-f0c9ce935a44SPL set ID e5c21813-4714-4f23-be8b-765bd58f63b3RxCUI 898589, 898601, 898605

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N467457075610 followed by a unit qualifier and the quantity

Package 67457-0756-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 21, 2026.

Indications (excerpt from the label)

Octreotide acetate for injectable suspension 10 mg, 20 mg, and 30 mg is indicated in patients in whom initial treatment with octreotide acetate injection has been shown to be effective and tolerated. Octreotide acetate for injectable suspension is a somatostatin analogue indicated for: Treatment in patients who have responded to and tolerated octreotide acetate injection subcutaneous injection for: • Acromegaly ( 1.1 ) • Severe diarrhea/flushing episodes associated with metastatic carcinoid tumors ( 1.2 ) • Profuse watery diarrhea associated with Vasoactive Intestinal Peptide (VIP) secreting tumors ( 1.3 ) 1.1 Acromegaly Long-term maintenance therapy in acromegalic patients who have had an i…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 67457-756

What is NDC 67457-756?: 67457-756 is the product NDC for Octreotide Acetate kit, listed with the FDA by Mylan Institutional LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Octreotide Acetate.
Who is the labeler?: Mylan Institutional LLC, NDC labeler code 67457. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Octreotide Acetate?: 28 other product NDCs are listed under this name. See all Octreotide Acetate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Octreotide Acetate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Octreotide Acetate	—	Kit	Mylan Institutional LLC	67457-759	67457-0759-20
Octreotide Acetate	—	Kit	Mylan Institutional LLC	67457-762	67457-0762-30
Octreotide Acetate	—	KitIntramuscular	Teva Pharmaceuticals, Inc.	0480-9257	00480-9257-08
Octreotide Acetate	Octreotide acetate 500 ug/mL	Injection, SolutionIntravenous, Subcutaneous	Meitheal Pharmaceuticals, Inc.	71288-568	71288-0568-02
Octreotide Acetate	Octreotide acetate 50 ug/mL	Injection, SolutionIntravenous, Subcutaneous	Meitheal Pharmaceuticals, Inc.	71288-566	71288-0566-02
Octreotide Acetate	Octreotide acetate 100 ug/mL	Injection, SolutionIntravenous, Subcutaneous	Meitheal Pharmaceuticals, Inc.	71288-567	71288-0567-02
Octreotide Acetate	—	KitIntramuscular	Teva Pharmaceuticals, Inc.	0480-9259	00480-9259-08
Octreotide Acetate	—	KitIntramuscular	Teva Pharmaceuticals, Inc.	0480-9262	00480-9262-08
Octreotide Acetate	Octreotide acetate 100 ug/mL	Injection, SolutionIntravenous, Subcutaneous	Hainan Shuangcheng Pharmaceuticals Co., Ltd.	52958-046	52958-0046-10
Octreotide Acetate	Octreotide acetate 100 ug/mL	Injection, SolutionIntravenous, Subcutaneous	GLENMARK PHARMACEUTICALS INC., USA	68462-896	68462-0896-10

All 29 Octreotide Acetate NDCs

Other NDCs under ANDA 216589

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216589
Product	Strength	Form · route	Labeler	Product NDC
Octreotide Acetate	—	Kit	Mylan Institutional LLC	67457-759
Octreotide Acetate	—	Kit	Mylan Institutional LLC	67457-762